This stock trades on the Alberta Stock Exchange (that is somewhere North of
Montana I think :-) as SYB. The company is HQd in Calgary AB, and has been
around for a few years. Not fly by night.
The company is developing several products to treat fatal forms of
diarrhoea. IE CALGARY, March 12 /CNW/ - SYNSORB Biotech Inc. (SBI, the
Corporation) announces that it has completed its Phase II/III
clinical trial in Canada for the treatment of patients with
hemorraghic colitis, commonly known as ``Hamburger Disease''. ...further
details are in www.newswire.ca
The corporation is not yet profitable. Trading around $3, it now spends
about $2.5 million per year in research. On Jan 16 1996, SBI was awarded
US patent 5484773 in regard to its invention, Synsorb. The chap I talked to
at Synsorb Biotech cautiously indicated it may become profitable in early 1997.
So this is an investment, not a day trade. Check out the chart.
Suggest what it might be worth in 1997 if it is better than Dr. Fowler's
remedy, Kaopectate, etc. And consider that it treats diarrhoea that is fatal,
and cannot be treated by Vancomycin (a $300 per day antibiotic.)
Is $10 to $30 in late 1997 unreasonable?
Share your expertise!
Fred Bealle
Toronto
|
